A novel mutation at the invariant acceptor splice site of intron 9 in the HEXA gene [IVS9‐1 G→T] detected by a PCR‐based diagnostic test

David H. Brown,B. Triggs-Raine,M. Mcginniss,M. Kaback

DOI: https://doi.org/10.1002/humu.1380050211

Human Mutation

Abstract:Tay-Sachs disease, a fatal neurodegenerative disease of infancy, is transmitted with a recessive pattern of inheritance and is particularly frequent among infants of Ashkenazi Jewish heritage (Sandhoff et al., 1989). The disease re:sults from mutations in the HEXA gene encoding the a-subunit of the rxp dimer, p-hexosaminidase '4 (Hex A). Population-based screening programs, employing serum and leukocyte Hex A profiles, de:jigned for disease prevention have contributed substantially to dramatic reductions in the incidence of lay-Sachs disease in the past two decades (Kaback et al., 1993). Many mutations have been identified in the HEXA gene. Three mutations, -t TATC in exon 11 (Myerowitz and Costigan, 1988), IVS12+ 1 G-tC (Myerowitz, 1988; Arpaia et al., 1988; Ohno and Suzuki, 1988), and G805A in exon 7 (Paw et al., 1989; Navon and Proia, 1989) account for most mutations in the Ashkenazi Jewish population (reviewed in Neufeld, 1991). Many laboratories now supplement enzyme screening with DNA diagnostic tests for these mutations. In nc'n-Jewish populations, three different mutations are sufficiently frequent to also be used as supplements to enzymatic testing. Among these are the t w o benign mutations, C739T and C745T (Triggs-Raine et al., 1992; Cao et al., 1993) and the disease-causing mutation 1VS9+ 1 G+A (Akli et al., 1991). Serum and leukocyte samples from both parents of a patient with Tay-Sachs disease were found to have carrier levels of Hex A activity. DNA from these individuals was analyzed for mutations commonly found to cause Tay-Sachs disease. The 4-bp insertion in exon 11 was identified in the DNA sample from the Ashkenazi Jewish father. None of the mutations common in the Ashkenazi Jewish population was identified in the non-Jewish moth-